TY  - GEN
AU  - Lelli,G
AU  - Cataldo,S
AU  - Carandina,I
AU  - Urbini,B
AU  - Bonetti,F
AU  - Marzola,M
AU  - Biasco,G
AU  - Pantaleo,M A
AU  - Brandes,A
AU  - Calandri,C
AU  - Ravaioli,E
AU  - Nanni,O
AU  - Boni,C
AU  - Banzi,C
AU  - Negri,F
AU  - Panetta,A
AU  - DI Fabio,F
AU  - Turci,D
TI  - The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice
SN  - 1973-9478
PY  - 2008///0804
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Camptothecin
KW  - Cetuximab
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Irinotecan
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Retrospective Studies
KW  - Skin
KW  - drug effects
KW  - Skin Diseases
KW  - chemically induced
KW  - Weight Loss
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1179/joc.2008.20.3.374
ER  -